The 2024 interim report of Frontier Bio shows that the company achieved revenue of 51.056 million yuan in the first half of the year, an increase of 20.30% YoY; the net income attributable to shareholders of the listed company was a loss of 0.16 billion yuan.
前沿生物：上半年净利润亏损1.6亿元
Frontier Bio: The net income for the first half of the year was a loss of 0.16 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated